Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Operating Expenses | 23,096 | 61,582 | 42,906 | 50,862 | 53,727 |
| Operating Income | -23,096 | -61,582 | -42,906 | -50,862 | -53,727 |
| Interest Expense | -1,132 | 1,736 | 1,630 | 1,629 | 1,663 |
| Other Income | 1,824 | 445 | 295 | 79 | 369 |
| Pre-tax Income | -20,140 | -62,873 | -44,241 | -52,412 | -55,021 |
| Net Income Continuous | -20,140 | -62,873 | -44,241 | -52,412 | -55,021 |
| Net Income | $-20,140 | $-62,873 | $-44,241 | $-52,412 | $-55,021 |
| EPS Basic Total Ops | -0.22 | -0.70 | -0.49 | -0.58 | -0.61 |
| EPS Basic Continuous Ops | -0.22 | -0.70 | -0.49 | -0.58 | -0.61 |
| EPS Diluted Total Ops | -0.22 | -0.70 | -0.49 | -0.58 | -0.61 |
| EPS Diluted Continuous Ops | -0.22 | -0.70 | -0.49 | -0.58 | -0.61 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.37 | -0.49 | -0.58 | -0.61 |
| EBITDA(a) | $-22,669 | $-58,913 | $-41,307 | $-49,303 | $-50,335 |